Burden of basal cell carcinoma in USA Journal Article
| Authors: | Wu, X.; Elkin, E. E.; Marghoob, A. A. |
| Article Title: | Burden of basal cell carcinoma in USA |
| Abstract: | Basal cell carcinoma (BCC) is the most common malignancy diagnosed in the USA and its incidence continues to increase. While BCC is still most prevalent in the older segments of the population, it is becoming ever more frequent in younger individuals. The costs of treatment and morbidity associated with BCCs place a heavy public health and economic burden on patients, their families and the American healthcare system and underscore the importance of efficient management and prevention efforts directed toward this malignancy. In this article, we address economic aspects of BCC using evidence from large-scale epidemiological studies. This information may help clinicians in developing better and more cost-effective methods for dealing with the most common cancer in America and in the world. © 2015 Future Medicine Ltd. |
| Keywords: | basal cell carcinoma; skin neoplasms; morbidity; skin cancer; medicare; economics; registries; population; epidemiology; cost; cost-effectiveness; trends; procedures; burden; usa; treatment modality; healthcare; cost analysis; incidence nonmelanoma; treatment pattern |
| Journal Title: | Future Oncology |
| Volume: | 11 |
| Issue: | 22 |
| ISSN: | 1479-6694 |
| Publisher: | Future Medicine |
| Date Published: | 2015-01-01 |
| Start Page: | 2967 |
| End Page: | 2974 |
| Language: | English |
| DOI: | 10.2217/fon.15.180 |
| PROVIDER: | scopus |
| PUBMED: | 26466906 |
| DOI/URL: | |
| Notes: | Export Date: 2 December 2015 -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work